Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gilat Satellite Ntwk (NQ: GILT )

5.260 +0.020 (+0.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Gilat Satellite Ntwk

< Previous 1 2 Next >
From Pennies to Paydays: 3 Stocks Set to Skyrocket in 5 Years
If you want extreme upside, you need to take big risks in the hopes of big rewards. These stocks set to skyrocket might help. 
Via InvestorPlace
The Bargain Stock Blitz: 7 Companies Ready to Stun the Street
While going off-roading in the market can be treacherous, investors willing to risk it with bargain stocks could be rewarded. 
Via InvestorPlace
Gilat's Strategic Acquisitions Fuel Growth Amid Slight Revenue Shortfall
Gilat(NASDAQ: GILT) reported Q1 2024 revenue of $76.08M, missing analyst estimate. Adjusted EPS of $0.11 beat estimate. Cash on hand was $105.1M. 
Via Benzinga
GILT Stock Earnings: Gilat Satellite Networks Beats EPS, Misses Revenue for Q1 2024
GILT stock results show that Gilat Satellite Networks beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Cheap Tricks: 7 Beaten-Down Tech Stocks to Buy Before the Comeback
Although these beaten-down tech stocks present volatility risks, speculators also have a chance for significant upside. 
Via InvestorPlace
Gilat Satellite Networks's Earnings Outlook
Via Benzinga
Why Are Gilat Satellite Networks Shares Trading Higher Today
Via Benzinga
Gilat Satellite Networks Clocks 21% Revenue Growth In Q3 Aided By End-Market Recovery
Via Benzinga
Gilat Wins Client To Extend 4G Coverage for Mobile Operators In Latin America
Via Benzinga
Gilat Satellite Networks Eyes Defense Sector Growth After DataPath Acquisition, Beats Q4 EPS Estimates
Gilat Satellite Networks Posts Q4 Revenue Growth, Eyes Defense Sector Expansion with DataPath Acquisition. Adjusted EPS beats estimates as Gilat sets optimistic FY24 outlook. 
Via Benzinga
Earnings Scheduled For February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million. 
Via Benzinga
Gilat Shares Drop Premarket On Q2 Revenue Miss; Reiterates FY22 Outlook
Via Benzinga
Gilat Clocks 19% Revenue Growth In Q1 Aided By Additional Orders, Broadening Pipeline
Via Benzinga
3 Stocks Capitalizing on the Space Internet Revolution
These space stocks are pioneering new internet technologies with their satellite constellations. Here are the best companies to buy. 
Via InvestorPlace
Gilat Satellite Networks Posts Q3 Profit Leap, Tightens Revenue Forecast
Gilat Satellite Networks Ltd (NASDAQ: GILT) reported third-quarter FY23 revenue growth of 6% year-on-year to $63.9 million, missing the  
Via Benzinga
Middle East War Hammers Israel-Based Stocks But Lifts Defense, Oil Names
Israel stocks, regardless of industry, sank Monday following the terrorist attack on Israel. 
Via Investor's Business Daily
Tesla, Mirati Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures traded lower this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Gilat Clocks 58% Revenue Growth In Q4 Backed By Fixed Networks, Mobility Solutions Growth
Via Benzinga
Gilat Satellite Q2 Takes Off, CEO 'Confident About Our Ability To Materialize Our Long-Term Growth Potential'
Gilat Satellite Networks Ltd. (NASDAQ: GILT) reported second-quarter FY23 revenue growth of 22% year-on-year to $67.6 million versus consensus $63.84 million.&nb 
Via Benzinga
Gilat Satellite Networks Positioned for Profitability Surge: Analyst Predicts Uptick in Peru Business
Needham analyst Ryan Koontz initiates coverage on Gilat Satellite Networks Ltd (NASDAQ: GILT) with a Buy rating and a  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's session, 99 companies made new 52-week lows. 
Via Benzinga
Gilat Satellite Networks Clocks 8% Revenue Growth In Q4; Names New Chair As Isaac Angel Set To Retire In March
Gilat Satellite Networks Ltd (NASDAQ: GILT) reported fourth-quarter FY22 revenue growth of 8% year-on-year to $72.6 million,  
Via Benzinga
Earnings Scheduled For May 23, 2022
Companies Reporting Before The Bell • Star Equity Hldgs (NASDAQ:STRR) is expected to report quarterly loss at $0.15 per share on revenue of $25.45 million. 
Via Benzinga
Earnings Scheduled For February 14, 2023
Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion. 
Via Benzinga
Recap: Gilat Satellite Networks Q4 Earnings
  Gilat Satellite Networks (NASDAQ:GILT) reported its Q4 earnings results on Tuesday, February 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Overview Of Value Stocks In The Technology Sector
The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may... 
Via Benzinga
61 Biggest Movers From Yesterday
Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa... 
Via Benzinga
Earnings Scheduled For February 15, 2022
Companies Reporting Before The Bell • FirstService (NASDAQ:FSV) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.07 billion. 
Via Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.